Literature DB >> 28279522

Home Blood Pressure Telemonitoring: Rationale for Use, Required Elements, and Barriers to Implementation in Canada.

Peter W Wood1, Pierre Boulanger2, Raj S Padwal3.   

Abstract

Contemporary hypertension guidelines strongly endorse the use of home blood pressure (BP) monitoring for hypertension diagnosis and management. However, barriers exist that prevent optimal use of home BP measurements. Patients might not follow the recommended home BP measurement protocol, might not take the required number of readings, and/or might report only selected readings to their providers. Providers might not calculate the mean (used for clinical decision-making) and/or incorporate home BP measurements into the medical record. Use of home BP telemonitoring, defined as the process by which home BP readings are securely teletransmitted and summarized within a health care portal or electronic medical record for provider use, might overcome these barriers. Telemonitoring, especially when combined with protocolized case management, leads to statistically significant and clinically important BP reductions, and improvements in overall BP control. Despite evidence supporting its use, home BP telemonitoring is not widely used in Canada. Barriers to adoption can be classified as structural and financial. Although technological advancements have made telemonitoring highly feasible, infrastructure is lacking, and implementation remains a challenge; this is especially true with respect to creating simple and cost-effective systems that are user-friendly and acceptable to patients as well as to providers. Ensuring data security is crucial to successful implementation, as is developing appropriate reimbursement models for providers. If these barriers can be overcome, home BP telemonitoring has the potential to make care provision easier and more convenient for patients and providers, while improving BP control in Canadians with hypertension.
Copyright © 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28279522     DOI: 10.1016/j.cjca.2016.12.018

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  Opportunity for Pharmacists in Telehealth, Team-Based Care: Clinical Inertia.

Authors:  Logan T Murry; Korey Kennelty
Journal:  Telemed J E Health       Date:  2020-01-22       Impact factor: 3.536

2.  Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.

Authors:  Raj S Padwal; Helen So; Peter W Wood; Finlay A Mcalister; Muzaffar Siddiqui; Colleen M Norris; Tom Jeerakathil; James Stone; Shelley Valaire; Balraj Mann; Pierre Boulanger; Scott W Klarenbach
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-20       Impact factor: 3.738

3.  Assessing the routine-practice gap for home blood pressure monitoring among Chinese adults with hypertension.

Authors:  Hui-Juan Zuo; Ji-Xiang Ma; Jin-Wen Wang; Xiao-Rong Chen
Journal:  BMC Public Health       Date:  2020-11-23       Impact factor: 3.295

Review 4.  Developments in Privacy and Data Ownership in Mobile Health Technologies, 2016-2019.

Authors:  Hannah K Galvin; Paul R DeMuro
Journal:  Yearb Med Inform       Date:  2020-08-21

5.  Home blood pressure telemonitoring in the 21st century.

Authors:  Gianfranco Parati; Eamon Dolan; Richard J McManus; Stefano Omboni
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07       Impact factor: 3.738

6.  Chinese Mobile Health APPs for Hypertension Management: A Systematic Evaluation of Usefulness.

Authors:  Jun Liang; Xiaojun He; Yuxi Jia; Wei Zhu; Jianbo Lei
Journal:  J Healthc Eng       Date:  2018-03-18       Impact factor: 2.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.